Heidelberg Pharma AG Statistics

Total Valuation

LON:0QW5 has a market cap or net worth of GBP 191.56 million. The enterprise value is 173.88 million.

Market Cap	191.56M
Enterprise Value	173.88M

Important Dates

The last earnings date was Thursday, July 10, 2025.

Earnings Date	Jul 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	46.60M
Shares Outstanding	n/a
Shares Change (YoY)	+1.47%
Shares Change (QoQ)	-5.70%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	9.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	33.81
PB Ratio	9.24
P/TBV Ratio	14.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.10
EV / Sales	29.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.53

Financial Position

The company has a current ratio of 7.15, with a Debt / Equity ratio of 0.01.

Current Ratio	7.15
Quick Ratio	4.78
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-592.23

Financial Efficiency

Return on equity (ROE) is -59.35% and return on invested capital (ROIC) is -40.11%.

Return on Equity (ROE)	-59.35%
Return on Assets (ROA)	-26.48%
Return on Invested Capital (ROIC)	-40.11%
Return on Capital Employed (ROCE)	-51.33%
Revenue Per Employee	53,960
Profits Per Employee	-163,986
Employee Count	105
Asset Turnover	0.12
Inventory Turnover	0.15

Taxes

Income Tax	-40,456
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +61.89% in the last 52 weeks. The beta is -0.28, so LON:0QW5's price volatility has been lower than the market average.

Beta (5Y)	-0.28
52-Week Price Change	+61.89%
50-Day Moving Average	3.73
200-Day Moving Average	3.34
Relative Strength Index (RSI)	57.45
Average Volume (20 Days)	186

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0QW5 had revenue of GBP 5.67 million and -17.22 million in losses. Loss per share was -0.37.

Revenue	5.67M
Gross Profit	4.18M
Operating Income	-20.05M
Pretax Income	-17.26M
Net Income	-17.22M
EBITDA	-19.44M
EBIT	-20.05M
Loss Per Share	-0.37

Full Income Statement

Balance Sheet

The company has 17.10 million in cash and 125,583 in debt, giving a net cash position of 16.97 million.

Cash & Cash Equivalents	17.10M
Total Debt	125,583
Net Cash	16.97M
Net Cash Per Share	n/a
Equity (Book Value)	20.72M
Book Value Per Share	0.44
Working Capital	28.26M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -22.67 million and capital expenditures -419,648, giving a free cash flow of -23.09 million.

Operating Cash Flow	-22.67M
Capital Expenditures	-419,648
Free Cash Flow	-23.09M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	73.80%
Operating Margin	-353.88%
Pretax Margin	-304.62%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0QW5 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.47%
Shareholder Yield	n/a
Earnings Yield	-8.99%
FCF Yield	-12.06%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 7, 2017. It was a forward split with a ratio of 1.0464082038.

Last Split Date	Nov 7, 2017
Split Type	Forward
Split Ratio	1.0464082038

Scores

LON:0QW5 has an Altman Z-Score of -6.89 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.89
Piotroski F-Score	1